Additionally, boosting the expression of these receptors may be a therapeutic strategy for the treatment of AD because levels of ApoE LDL receptors directly correlate with the clearance of Aβ (Penke et al., 2019). The gene discussed is APOE; the disease is Alzheimer disease.